Kallmann R et al. |
Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects. |
1987 |
Thromb. Res. |
pmid:3576521
|
Schorer AE |
Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody. |
1997 |
Thromb. Res. |
pmid:9062953
|
Kosaki G et al. |
The mechanism of the inhibitory effect of protease inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids. |
1980 Dec 1-15 |
Thromb. Res. |
pmid:6785893
|
Anfossi G et al. |
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. |
1995 |
Thromb. Res. |
pmid:7778055
|
Watanabe T et al. |
Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. |
2001 |
Thromb. Res. |
pmid:11672751
|
Carroll RC et al. |
Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance. |
2010 |
Thromb. Res. |
pmid:19962724
|
Lee GY et al. |
Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester. |
2005 |
Thromb. Res. |
pmid:15668191
|
Ziegler BK et al. |
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. |
2001 |
Thromb. Res. |
pmid:11672759
|
Ersöz G et al. |
The effect of submaximal exercise on platelet aggregation during late follicular and midluteal phases in women. |
2002 |
Thromb. Res. |
pmid:12590951
|
Kawamura M et al. |
Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. |
1995 |
Thromb. Res. |
pmid:7778061
|
Winter M et al. |
Synthesis of thromboxane B2 in uraemia and the effects of dialysis. |
1983 |
Thromb. Res. |
pmid:6868024
|
Ersöz G et al. |
Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. |
2003 |
Thromb. Res. |
pmid:14698654
|
Teng CM et al. |
Two antiplatelet agents from Magnolia officinalis. |
1988 |
Thromb. Res. |
pmid:3413728
|
Addonizio VP et al. |
Inhibition of human platelet function by verapamil. |
1982 |
Thromb. Res. |
pmid:7164035
|
Pekonen F et al. |
Platelet function and coagulation in normal and preeclamptic pregnancy. |
1986 |
Thromb. Res. |
pmid:2944245
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Vlodavsky I et al. |
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. |
1982 |
Thromb. Res. |
pmid:7179215
|
Cholette JM et al. |
Aspirin resistance following pediatric cardiac surgery. |
2010 |
Thromb. Res. |
pmid:20550971
|
Umemura K et al. |
Effect of dietary docosahexaenoic acid in the rat middle cerebral artery thrombosis model. |
1995 |
Thromb. Res. |
pmid:7660354
|
Chou TC and Li CY |
Inhibitory mechanisms of dantrolene on platelet aggregation. |
1999 |
Thromb. Res. |
pmid:10593433
|
Carter AJ et al. |
Human pulmonary vessels obtained from necropsy produce less prostacyclin and thromboxane than fresh vessels obtained from operations. |
1984 |
Thromb. Res. |
pmid:6547546
|
Cerskus AL et al. |
Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits. |
1978 |
Thromb. Res. |
pmid:653641
|
Hernández R et al. |
Influence of co-incubation and cell number of platelets and polymorphonuclear leukocytes in cellular inhibition and activation phenomena. |
1994 |
Thromb. Res. |
pmid:8042192
|
Rousson D et al. |
Acute myocardial infarction: measurement of arachidonate end-products in whole blood as an index of platelet cyclo-oxygenase activity in vivo. |
1987 |
Thromb. Res. |
pmid:3122356
|
Hanasaki K and Arita H |
Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets. |
1988 |
Thromb. Res. |
pmid:2839912
|
Navran SS et al. |
Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. |
1984 |
Thromb. Res. |
pmid:6372157
|
Shorr RI et al. |
In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis. |
1985 |
Thromb. Res. |
pmid:3923647
|
Vanags D et al. |
The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery. |
1990 |
Thromb. Res. |
pmid:2264023
|
Ishikawa Y et al. |
Effect of cytoplasmic pH on platelet activation by arachidonic acid. |
1989 |
Thromb. Res. |
pmid:2499076
|
Kankuri E et al. |
Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro. |
2003 |
Thromb. Res. |
pmid:14592552
|
Lages B and Weiss HJ |
Inhibition of human platelet function in vitro and ex vivo by acetaminophen. |
1989 |
Thromb. Res. |
pmid:2499947
|
Küster LJ et al. |
Mechanism of PAF-induced platelet aggregation in man. |
1986 |
Thromb. Res. |
pmid:3764802
|
Reimers HJ et al. |
Impaired thromboxane synthesis in preactivated human blood platelets: agonist-specific, irreversible desensitization to thrombin. |
1987 |
Thromb. Res. |
pmid:3126557
|
Stegmeier K et al. |
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug. |
1984 |
Thromb. Res. |
pmid:6385334
|
Mercer JB et al. |
The effect of short-term cold exposure on risk factors for cardiovascular disease. |
1999 |
Thromb. Res. |
pmid:10418798
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Hall ER et al. |
The reduction of platelet thrombi on damaged vessel wall by a thromboxane synthetase inhibitor in rabbits. |
1982 |
Thromb. Res. |
pmid:6891109
|
Lukasik M et al. |
Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. |
2011 |
Thromb. Res. |
pmid:21788065
|
Davis RB et al. |
Evaluation of platelet function in pregnancy. Comparative studies in non-smokers and smokers. |
1987 |
Thromb. Res. |
pmid:2955542
|
Gerrard JM et al. |
Studies in patients with bleeding disorders show that platelet-vessel interaction is important for thromboxane formation in bleeding time wounds. |
1990 |
Thromb. Res. |
pmid:2278038
|
Suehiro A et al. |
The role of platelet hyperfunction in thrombus formation in hyperlipidemia. |
1982 |
Thromb. Res. |
pmid:6803387
|
Ali M et al. |
Synthesis of prostaglandin D2 and thromboxane B2 by human platelets. |
1977 |
Thromb. Res. |
pmid:918907
|
Vericel E et al. |
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. |
1988 |
Thromb. Res. |
pmid:3129819
|
Wang JP et al. |
Antiplatelet effect of capsaicin. |
1984 |
Thromb. Res. |
pmid:6528310
|
Cattaneo M et al. |
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. |
1991 |
Thromb. Res. |
pmid:1926062
|
Udvardy M et al. |
Alterations of primary haemostasis in mixed connective tissue disease (MCTD). |
1991 |
Thromb. Res. |
pmid:1835548
|
Koh H et al. |
A radioimmunoassay of thromboxane B2 with thromboxane B2-125I-tyramide and its application to the study on the thromboxane B2 formation during platelet aggregation. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:7368170
|
Kohda N et al. |
Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. |
1999 |
Thromb. Res. |
pmid:10593428
|
Marasini B et al. |
Cigarette smoking and platelet function. |
1986 |
Thromb. Res. |
pmid:3787563
|
Matsuo T et al. |
A new thrombin inhibitor MD805 and thrombocytopenia encountered with heparin hemodialysis. |
1986 |
Thromb. Res. |
pmid:3787568
|
Deckmyn H et al. |
Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. |
1983 |
Thromb. Res. |
pmid:6344317
|
Nosál' R et al. |
Chloroquine: a multipotent inhibitor of human platelets in vitro. |
2000 |
Thromb. Res. |
pmid:10828481
|
Buchanan MR et al. |
The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects. |
1983 |
Thromb. Res. |
pmid:6221436
|
Neiman J et al. |
Composition of platelet phosphatidylinositol and phosphatidylcholine after ethanol withdrawal. |
1987 |
Thromb. Res. |
pmid:3603426
|
Randall MJ and Wilding RI |
Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01). |
1982 |
Thromb. Res. |
pmid:6897751
|
Di Minno G and Violi F |
Aspirin resistance and diabetic angiopathy: back to the future. |
2004 |
Thromb. Res. |
pmid:15115664
|
Vesterqvist O et al. |
Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. |
1984 |
Thromb. Res. |
pmid:6695361
|
Zijlstra FJ et al. |
Thrombotic thrombocytopenic purpura and plasma thromboxane B2 levels. |
1983 |
Thromb. Res. |
pmid:6684333
|
Todd MK et al. |
Effect of exercise intensity on 6-keto-PGF1 alpha, TXB2, and 6-keto-PGF1 alpha/TXB2 ratios. |
1992 |
Thromb. Res. |
pmid:1615492
|
Dembinska-Kiec A et al. |
Ticlopidine and platelet function in healthy volunteers. |
1992 |
Thromb. Res. |
pmid:1615496
|
Sandler H et al. |
Studies on the role of thromboxane in thrombin-induced pulmonary insufficiency in the rat. |
1986 |
Thromb. Res. |
pmid:3754987
|
Maguire ED and Wallis RB |
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat. |
1983 |
Thromb. Res. |
pmid:6689221
|
Hashimoto Y et al. |
Characteristics of protein kinase C-independent exocytosis in human platelets. |
1997 |
Thromb. Res. |
pmid:9336873
|
Igawa T et al. |
Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. |
1990 |
Thromb. Res. |
pmid:2158154
|
Di Minno MN et al. |
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. |
2011 |
Thromb. Res. |
pmid:21669453
|
Ames PR et al. |
Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus. |
2012 |
Thromb. Res. |
pmid:22521214
|
McGill D et al. |
Platelet function and exercise-induced myocardial ischaemia in coronary heart disease patients. |
1989 |
Thromb. Res. |
pmid:2533414
|
Martin JF et al. |
The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. |
1983 |
Thromb. Res. |
pmid:6658722
|
Li C et al. |
Aspirin response variability after major orthopedic surgery. |
2012 |
Thromb. Res. |
pmid:22575418
|
Vesterqvist O et al. |
In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. |
1985 |
Thromb. Res. |
pmid:3992528
|
Chiang TM and Kang AH |
The effect of platelet surface protein phosphorylation on collagen-platelet interaction. |
1986 |
Thromb. Res. |
pmid:3810565
|
Serebruany VL and Gurbel PA |
Assessment of platelet activity by measuring platelet-derived substances in plasma from patients with acute myocardial infarction: surprising lessons from the GUSTO-III Platelet Study. |
1999 |
Thromb. Res. |
pmid:10030832
|
Croft KD and Beilin LJ |
Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia. |
1993 |
Thromb. Res. |
pmid:8385810
|
Hofmann D et al. |
Evidence for sustained platelet activation in patients with early postinfarction angina. |
1993 |
Thromb. Res. |
pmid:8303651
|
Toft G et al. |
Intravenously and topically applied magnesium in the prevention of arterial thrombosis. |
2000 |
Thromb. Res. |
pmid:10904104
|
Knapp HR et al. |
Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men. |
1988 |
Thromb. Res. |
pmid:3293263
|
Sinzinger H et al. |
Response of thromboxane B2, malondialdehyde and platelet sensitivity to 3 weeks low-dose aspirin (ASA) in healthy volunteers. |
1989 |
Thromb. Res. |
pmid:2497545
|
Pirich C et al. |
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. |
1999 |
Thromb. Res. |
pmid:10588465
|
De Caterina R et al. |
Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. |
1985 |
Thromb. Res. |
pmid:3975876
|
Worthington RE and Fuller GC |
Dibutyryl cyclic guanosine monophosphate elevates bovine endothelial cell thromboxane production without affecting prostacyclin metabolism. |
1984 |
Thromb. Res. |
pmid:6322377
|
Selley ML et al. |
The effect of cholesterol oxidation products on human platelet aggregation. |
1996 |
Thromb. Res. |
pmid:8885139
|
Kritz H et al. |
Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished. |
1995 |
Thromb. Res. |
pmid:8610276
|
Bergqvist D et al. |
The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis. |
1985 |
Thromb. Res. |
pmid:3838828
|
Kelton JG et al. |
Sex-related differences in the efficacy of acetylsalicylic acid (ASA) : the absorption of ASA and its effect on collagen-induced thromboxane B2 generation. |
1981 Oct 1-15 |
Thromb. Res. |
pmid:7330835
|
Yamaguchi A et al. |
Effect of cetiedil on platelet aggregation and thromboxane synthesis. |
1985 |
Thromb. Res. |
pmid:2986312
|
Lai LJ et al. |
Trilinolein inhibits epinephrine-induced human platelet aggregation. |
1994 |
Thromb. Res. |
pmid:7863478
|
Domoto DT et al. |
Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. |
1991 |
Thromb. Res. |
pmid:1926064
|
Ding YA et al. |
Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound. |
1995 |
Thromb. Res. |
pmid:7740521
|
Wang JP et al. |
XC 386: a new antiplatelet agent. |
1984 |
Thromb. Res. |
pmid:6438827
|
Schorer AE and White JG |
Interleukin 1 enhances arterial thrombogenicity in vitro. |
1989 |
Thromb. Res. |
pmid:2609290
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Tzeng SH et al. |
Inhibition of platelet aggregation by some flavonoids. |
1991 |
Thromb. Res. |
pmid:1776142
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Udvardy M et al. |
Altered primary haemostasis in Conn's syndrome. |
1992 |
Thromb. Res. |
pmid:1448795
|
Altman R et al. |
Why single daily dose of aspirin may not prevent platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3140408
|
Simmet T and Weide I |
Thromboxane and cysteinyl-leukotriene formation are differentially activated in spontaneously clotting whole human blood in vitro. |
1991 |
Thromb. Res. |
pmid:1866709
|
Lukaszyk A et al. |
Does acute experimental pancreatitis affect blood platelet function? |
1989 |
Thromb. Res. |
pmid:2524119
|
Delvos U et al. |
Direct radioimmunological measurement of thromboxane B2 in plasma. |
1985 |
Thromb. Res. |
pmid:4082109
|
Swart SS et al. |
Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. |
1984 |
Thromb. Res. |
pmid:6326344
|
Meyers KM et al. |
An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink, and man. |
1980 |
Thromb. Res. |
pmid:7209869
|